Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Monto AS et al. – In the 2007–2008 season, the inactivated vaccine was efficacious in preventing laboratory–confirmed symptomatic influenza A (predominately H3N2) in healthy adults. The live attenuated vaccine also prevented influenza illnesses but was less efficacious.

Related Articles

Update on 2009 pandemic influenza A (H1N1) virus
Cleveland Clinic Journal of Medicine, 10/05/09    Relevance Score: 95%

The first Pandemic of the 21st Century: A Review of the 2009 Pandemic Variant Influenza A (H1N1) Virus
Postgraduate Medicine, 10/02/09    Relevance Score: 95%

Importance of Routine Public Health Influenza Surveillance: Detection of an Unusual W-Shaped Influenza Morbidity Curve
American Journal of Epidemiology, 11/11/09    Relevance Score: 94%

Bacterial Coinfections in Lung Tissue Specimens From Fatal Cases of 2009 Pandemic Influenza A (H1N1)--United States, May-August 2009
JAMA, 11/04/09    Relevance Score: 94%

Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza
Evidence-based Complementary and Alternative Medicine, 10/05/09    Relevance Score: 94%

Today in Vaccine/Immunotherapy...keeping you current

DNA vaccines for biodefense
Expert Review of Vaccines, 12/08/09

Prospects for new plague vaccines
Expert Review of Vaccines, 12/08/09

Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines
Expert Review of Vaccines, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address